| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2000;35:673.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
p38 MAP Kinase Is Required for Vasopressin-Stimulated HSP27 Induction in Aortic Smooth Muscle Cells
From the Department of Pharmacology (T.I., K.T., M.N., H.M., T.U.) and Department of Neurosurgery (T.I., N.S.), Gifu University School of Medicine, Gifu, Japan; and the Department of Biochemistry (H.I., K.K.), Institute for Developmental Research, Aichi Human Service Center, Kasugai, Aichi, Japan.
Correspondence to Osamu Kozawa, MD, PhD, Department of Pharmacology, Gifu University School of Medicine, Gifu 500-8705, Japan.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract—We previously showed that arginine vasopressin (AVP) stimulates heat shock protein 27 (HSP27) induction through protein kinase C activation in aortic smooth muscle A10 cells. In the present study, we examined whether the mitogen-activated protein (MAP) kinase superfamily is involved in the AVP-stimulated HSP27 induction in A10 cells. AVP stimulated the phosphorylation of p42/p44 MAP kinase and p38 MAP kinase. On the contrary, AVP had little effect on SAPK (stress-activated protein kinase)/JNK (c-Jun N-terminal kinase) phosphorylation. The HSP27 accumulation by AVP was not affected by PD98059, an inhibitor of the upstream kinase that activates p42/p44 MAP kinase. SB203580 and PD169316, specific inhibitors of p38 MAP kinase, suppressed the AVP-induced accumulation of HSP27. 12-O-tetradecanoylphorbol 13-acetate, an activator of protein kinase C, induced accumulation of HSP27 and was not inhibited by PD98059 but was inhibited by SB203580. Calphostin C and ET-18-OCH3, inhibitors of protein kinase C, reduced the phosphorylation of p38 MAP kinase by AVP. SB203580 and PD169316 suppressed the AVP-increased levels in mRNA for HSP27. Dissociation of the aggregated HSP27 to the dissociated HSP27 was induced by AVP. These results strongly suggest that p38 MAP kinase takes part in the pathway of the AVP-stimulated induction of HSP27 in vascular smooth muscle cells.
Key Words: protein kinases • vasopressins • aorta • muscle, smooth, vascular
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
When cells or organs are exposed to stress such as heat, they produce a set of proteins known as heat shock proteins (HSPs).1 HSPs are divided into 2 groups, low- and high-molecular-weight HSPs such as HSP90 and HSP70. HSP27 is a member of the family of low-molecular-weight HSPs with molecular masses from 15 to 30 kDa. HSP27 is present in various tissues and cells, especially in skeletal muscle cells and smooth muscle cells (SMC), as we showed previously.2 3 The functions of HSP27 are less understood than those of high-molecular-weight HSPs. As one of the functions, it is recognized that HSP27 may act as chaperones,1 like high-molecular-weight HSPs. In addition, evidence is accumulating that HSP27 participates in physiological processes such as modulation of actin filament and stability, growth, and secretion in several types of cells.1 These observations suggest that HSP27 may have important roles in diverse cellular functions. In vascular SMC, it has been reported that restraint stress induces HSP27 mRNA.4 However, neither the exact mechanism of HSP27 induction nor the roles have been fully clarified.
Vascular SMC play a crucial role in the pathogenesis of hypertension and atherosclerosis.5 Arginine vasopressin (AVP) is a vasoactive agent that stimulates the proliferation of vascular SMC6 and induces vasoconstriction.7 As for intracellular signaling in these cells, it has been shown that AVP induces phosphoinositide hydrolysis by phospholipase C through its binding to the V1 receptor8 and activates phospholipase D,9 10 which hydrolyzes phosphatidylcholine. Both types of hydrolysis result in the formation of diacylglycerol, a physiological activator of protein kinase C (PKC).11 12 The activation of PKC by AVP plays an important role in inducing proliferation of vascular SMC.13 In a previous study14 we have shown that AVP stimulates the induction of HSP27 through activation of PKC in an aortic SMC line, A10 cells.
The mitogen-activated protein (MAP) kinase superfamily plays a central role in intracellular signal transduction pathways initiated by a variety of extracellular stimuli.15 16 The specificity of the cellular response is recognized to be determined by the activation of a particular MAP kinase pathway in response to a given stimulus. The 3 MAP kinases, p42/p44 MAP kinase, p38 MAP kinase, and SAPK (stress-activated protein kinase)/JNK (c-Jun N-terminal kinase) are known as central elements used by mammalian cells to transduce the diverse messages.16 As for vascular SMC, p42/p44 MAP kinase has been reported to be activated and involved in the pathway of platelet-derived growth factor–stimulated proliferation.16 Both p42/p44 MAP kinase and p38 MAP kinase have been shown to be phosphorylated by angiotensin II.16 In addition, it has recently been reported that H2O2 activates p42/p44 MAP kinase and p38 MAP kinase.16 However, the exact roles of MAP kinase superfamily in vascular SMC have not yet been fully clarified.
In the present study, we studied the involvement of the MAP kinase superfamily in the AVP-stimulated HSP27 induction in aortic smooth muscle A10 cells. Our results show that p38 MAP kinase among MAP kinases takes part in the pathway of the AVP-stimulated induction of HSP27 and that p38 MAP kinase acts at a point downstream from PKC activation in the pathway.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Materials
AVP was purchased from Peptide Institute, Inc. PD98059, SB203580, PD169316, ET-18-OCH3, and bisindolylmaleimide were from Calbiochem-Novabiochem. 12-O-tetradecanoylphorbol 13-acetate (TPA) was from Sigma Chemical Co. Calphostin C was from Funakoshi Pharmaceutical Co. Phosphospecific p42/p44 MAP kinase antibodies, p42/p44 MAP kinase antibodies, phosphospecific p38 MAP kinase antibodies, p38 MAP kinase antibodies, phosphospecific SAPK/JNK antibodies, and SAPK/JNK antibodies were from New England BioLabs, Inc. The ECL Western blotting detection system was from Amersham. Other materials and chemicals were obtained from commercial sources. PD98059, SB203580, calphostin C, TPA, PD169316, ET-18-OCH3, and bisindolylmaleimide were dissolved in dimethyl sulfoxide. The maximum concentration of dimethyl sulfoxide was 0.1%, which did not affect the measurement made in the immunoassay of HSP27, Western blot analysis, nor Northern blot analysis.
Cell Culture
Aortic smooth muscle A10 cells were obtained from the American
Type Culture Collection and maintained as previously
described.14 In brief, the cells were seeded into 35-mm
(1x105) or 90-mm (5x105) diameter dishes.
After 5 days, the medium was exchanged for serum-free DMEM. After 48
hours, the cells were stimulated by AVP or TPA in serum-free DMEM for
the indicated periods. When indicated, the cells were pretreated with
PD98059, SB203580, calphostin C, PD169316, ET-18-OCH3, or
bisindolylmaleimide for 60 minutes before the stimulation.
Immunoassay of HSP27
The cultured cells were stimulated by AVP or TPA, rinsed twice
with PBS, and then frozen at -80°C for a few days before
analysis. The frozen cells in each dish were collected and
suspended in 0.3 mL of PBS, and each suspension was sonicated and
centrifuged at 125 000g for 20 minutes at 4°C.
The supernatant was used for the immunoassay of HSP27. The
concentrations of HSP27 in soluble extracts of the cells were
determined by sandwich-type enzyme immunoassays, as described
previously.2 3 Protein concentrations in soluble
extracts were determined with the use of a protein assay kit (Bio-Rad)
with BSA as the standard protein. Rat HSP27, which was used as the
standard for the immunoassay, was purified from skeletal
muscle.2 3
Sucrose Density Gradient Centrifugation
Extract of A10 cells was layered over a 3.5-mL linear gradient
of sucrose (10% to 40%) in 50 mmol/L Tris/HCl, pH 7.0, that
contained 5 mmol/L EDTA and was centrifuged at 4°C at
130 000g for 16 hours in a swinging bucket rotor (RPS56T;
Hitachi). After centrifugation, each sample was
fractionated into 15 test tubes, each of which contained 0.25 mL of
0.1% BSA.
Western Blot Analysis of p42/p44 MAP Kinase, p38 MAP
Kinase, and SAPK/JNK
The cultured cells were stimulated by AVP for the indicated
periods. Western blot analysis was performed as described
previously2 3 with each of the MAP kinase antibodies and
peroxidase-labeled antibodies raised in goat against rabbit IgG as
second antibodies. Peroxidase activity on the nitrocellulose sheet was
visualized on x-ray film by use of the ECL Western blotting detection
system.
Isolation of RNA and Northern Blot Analysis of mRNA
for HSP27
The cultured cells were stimulated by AVP for 12 hours. The
cells were then rinsed twice with PBS and frozen at -80°C for a few
days before analysis. Total RNA was isolated with the use of a
QuickPrep Total RNA Extraction kit (Pharmacia Biotech). Then, 20 µg
of total RNA was subjected to electrophoresis on a 0.9% agarose–2.2
mol/L formaldehyde gel and blotted onto a nitrocellulose membrane. For
Northern blotting, the membrane was allowed to hybridize with the cDNA
probe that had been labeled with a Multiprime DNA labeling system, as
described previously.17 A BamHI-Hind
III fragment of cDNA for mouse HSP2718 was kindly
provided by Dr Lyndon F. Cooper of the University of North
Carolina.
Statistical Analysis
The data were analyzed by a 1-way ANOVA, followed by the
Bonferroni method for multiple comparisons between pairs. A value of
P<0.05 was considered significant. All data are
presented as means±SD of triplicate determinations from 3
independent experiments.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Effect of AVP on Phosphorylation of p42/p44 MAP Kinase, p38 MAP Kinase, and SAPK/JNK in A10 Cells
We first examined the effect of AVP on the phosphorylation of p42/p44 MAP kinase, p38 MAP kinase, and SAPK/JNK. Stimulation by vasopressin significantly induced the phosphorylation of p42/p44 MAP kinase and p38 MAP kinase (Figure 1). The time courses in the phosphorylation of the 2 MAP kinases by AVP appeared to be quite different from each other. The phosphorylation of p42/p44 MAP kinase by AVP reached the peak at 5 minutes. On the other hand, the phosphorylation of p38 MAP kinase reached the peak at 20 minutes. However, AVP had little effect on the phosphorylation of SAPK/JNK (Figure 1).
|
Effect of PD98059 on AVP-Induced Accumulation of HSP27 in A10
Cells
To clarify the role of p42/p44 MAP kinase in the AVP-stimulated
induction of HSP27, we next examined the effect of PD98059, which is a
specific inhibitor of the upstream kinase that
activates p42/p44 MAP kinase.19 The concentration
of HSP27 in unstimulated A10 cells was 542±35 ng/mg protein. The
AVP-induced accumulation of HSP27 was not affected by PD98059 over the
range of 0.1 to 10 µmol/L (Figure 2). We found that PD98059 significantly
reduced the AVP-induced phosphorylation of p42/p44 MAP
kinase (Figure 3A).
|
) for 48 hours. Each value
represents mean±SD of triplicate determinations from 3
independent experiments.
|
Effects of SB203580 or PD169316 on AVP-Induced Accumulation of
HSP27 in A10 Cells
To clarify the role of p38 MAP kinase in the AVP-stimulated
induction of HSP27, we examined the effect of SB203580, a specific
inhibitor of p38 MAP kinase,20 on the
accumulation of HSP27 by AVP. We found that SB203580 also inhibited the
AVP-induced phosphorylation of p38 MAP kinase without
affecting the phosphorylation of p42/p44 MAP kinase by
AVP (Figure 3, B and C). The AVP-induced accumulation of HSP27
was significantly reduced by SB203580, which alone did not affect on
the basal levels of HSP27 (Figure 4, A
and B). The viability of the cells treated with SB203580 was >90%, as
assessed by trypan blue staining. The inhibitory effect of
SB203580 was dose-dependent over the range of 0.1 to 10 µmol/L.
The maximum effect of SB203580 was observed at 10 µmol/L, a dose
that caused 
90% reduction in the AVP effect. In addition, PD169316,
another inhibitor of p38 MAP kinase,21 reduced
the AVP-stimulated HSP27 accumulation (689±43 ng/mg protein for
0.1 µmol/L AVP; 396±35 ng/mg protein for 0.1 µmol/L AVP
with 10 µmol/L PD169316, as measured during the stimulation for
48 hours; values for unstimulated cells have been subtracted from each
data point).
|
Effects of PD98059 or SB203580 on TPA-Induced Accumulation of HSP27
in A10 Cells
We previously showed that AVP stimulates the induction of HSP27
through PKC activation in A10 cells.14 We confirmed that
the accumulation of HSP27 by AVP was reduced by bisindolylmaleimide, an
alternative inhibitor of PKC22 (675±40 ng/mg
protein for 0.1 µmol/L AVP; 359±30 ng/mg protein for 0.1
µmol/L AVP with 3 µmol/L bisindolylmaleimide, as measured
during the stimulation for 48 hours; values for unstimulated cells have
been subtracted from each data point). Thus we next examined the effect
of PD98059 or SB203580 on the accumulation of HSP27 by TPA, a
PKC-activating phorbol ester.12 The TPA-induced
accumulation of HSP27 was significantly reduced by 10 µmol/L
SB203580, although it was not affected by 10 µmol/L PD98059
(Table). SB20358 (10 µmol/L) caused
70% reduction in the TPA effect.
|
Effects of Calphostin C or ET-18-OCH3 on AVP-Induced
Phosphorylation of p38 MAP Kinase in A10 Cells
To clarify the effect of PKC on the AVP-induced
phosphorylation of p38 MAP kinase, we examined the
effects of highly specific PKC inhibitors, calphostin
C23 and ET-18-OCH3,24 on
phosphorylation. These inhibitors markedly
reduced the AVP-induced phosphorylation of p38 MAP
kinase (Figure 5, A and B).
|
Effects of SB203580 or PD169316 on mRNA Levels for HSP27 by AVP in
A10 Cells
We further examined the effects of SB203580 and PD169316 on the
expression levels of mRNA for HSP27 by AVP. The increase by AVP in the
mRNA levels for HSP27 was significantly reduced by SB203580 or PD169316
(Figure 6, A and B).
|
Dissociation of Aggregated Form of HSP27 by AVP in A10
Cells
HSP27 exists in 2 forms, an aggregated form and a dissociated
form.25 It is known that the dissociation of HSP27 occurs
concomitantly with the phosphorylation of HSP27, as
previously described.25 Our specific immunoassay of HSP27
detects both an aggregated form and a dissociated form, as previously
described.25 We investigated the response to AVP of the
aggregated form of HSP27. Extracts of unstimulated A10 cells contained
both forms, an aggregated form and a dissociated form (Figure 7). On the other hand, HSP27 in
AVP-stimulated A10 cells mainly showed a dissociated form (Figure 7).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
We previously showed that AVP stimulates the induction of HSP27 in aortic smooth muscle A10 cells and that the activation of PKC acts as a positive regulator in the induction of HSP27.14 In the present study, we examined whether or not the MAP kinase superfamily is involved in the AVP-stimulated HSP27 induction in A10 cells. AVP stimulated the significant phosphorylation of p42/p44 MAP kinase and p38 MAP kinase while having little effect on the phosphorylation of SAPK/JNK. It is well recognized that MAP kinase is activated by dual phosphorylation on threonine and tyrosine by specific MAP kinase kinase.26 Thus our findings suggest that AVP activates p42/p44 MAP kinase and p38 MAP kinase in A10 cells.
We showed that the AVP-induced accumulation of HSP27 was not affected
by PD98059, which reduced the phosphorylation of
p42/p44 MAP kinase by AVP. Therefore it seems unlikely that p42/p44 MAP
kinase is involved in the AVP-stimulated HSP27 induction. On the other
hand, SB203580 and PD169316 reduced the AVP-induced accumulation of
HSP27. We found that SB203580 actually inhibited the p38 MAP kinase
phosphorylation by AVP without affecting the p42/p44
MAP kinase phosphorylation by AVP. Thus these results
suggest that p38 MAP kinase is involved in the HSP27 induction by AVP.
Furthermore, to elucidate the role of p38 MAP kinase in the
AVP-stimulated induction of HSP27, we examined whether or not
inhibitors of p38 MAP kinase affect the mRNA levels for
HSP27. The increase by AVP in the mRNA levels for HSP27 was
significantly reduced by SB203580 or PD169316. On the basis of our
findings, it is most likely that the activation of p38 MAP kinase is
required for the AVP-stimulated HSP27 induction in A10 cells. As far as
we know, this is one of the first studies to show that the p38 MAP
kinase pathway mediates induction of HSP27 in vascular SMC. The p38 MAP
kinase superfamily consists of at least 4 different homologous
proteins: p38
, p38ß, p38
, and p38
.16 Among
these isoforms, p38 and p38ß are ubiquitously expressed. The
expression of p38 is most prominent in muscle. Each of these
isoforms contains a dual phosphorylation site on
threonine and tyrosine. Many of the properties of these isoforms are
very similar.16 However, it has recently been reported
that p38, unlike the other 3 p38 isoforms, shows a lack of
sensitivity to the inhibitory properties of pyridimyl
imidazoles such as SB203580.27 We showed herein that
SB203580 suppressed the HSP27 accumulation by AVP. Thus, taking these
results into account, it seems unlikely that p38 is involved in the
AVP-stimulated HSP27 induction in A10 cells.
The evidence of implication between p38 MAP kinase and HSP27 is accumulating in several cells, showing that the activation of p38 MAP kinase leads to the phosphorylation of HSP27.1 It is recognized that these phenomena are induced within 1 hour after stimulation. HSP27 exists in 2 forms, an aggregated form and a dissociated form. It is known that the dissociation of HSP27 occurs concomitantly with the phosphorylation of HSP27, as previously described.25 Thus we examined the possible existence of 2 forms of HSP27 in unstimulated or AVP-stimulated A10 cells. Extracts of unstimulated A10 cells contained both forms, an aggregated form and a dissociated form. On the contrary, HSP27 in AVP-stimulated A10 cells mainly showed a dissociated form. These findings suggest that AVP phosphorylates HSP27. We have reported that AVP significantly stimulates HSP27 induction after 36 hours from the stimulation.14 Taking our results into account, it is most likely that AVP not only phosphorylates HSP27 but also stimulates HSP27 induction in A10 cells.
In a previous study14 we have shown that AVP stimulates the induction of HSP27 by PKC activation in A10 cells. We demonstrated that the TPA-induced accumulation of HSP27 was reduced by SB203580. On the contrary, the HSP27 accumulation was not affected by PD98059. In addition, calphostin C and ET-18-OCH3, PKC inhibitors,23 24 suppressed the phosphorylation of p38 MAP kinase by AVP. Our results suggest that PKC acts at a point upstream from p38 MAP kinase in the AVP-stimulated induction of HSP27 in A10 cells.
Accumulating evidence indicates that HSP27 in vivo may act in the regulation of the structure and dynamics of actin filaments for an increased survival of cells recovering from stress.28 29 In addition, HSP27 has been reported to be associated with agonist-induced contraction of vascular SMC.30 On the other hand, it has been reported that the induction of HSP72 in vascular SMC before mechanical injury results in reduced proliferation without overt cytotoxicity.31 On the basis of these findings, it is probable that the induction of HSPs such as HSP27 by vasoactive agents might act protectively under hazardous conditions in vascular SMC. Investigations of HSPs in vascular SMC may contribute to vascular pathology such as hypertension, arteriosclerosis, and aging of vasculature. Further investigations would be required to clarify the details.
In conclusion, our results strongly suggest that p38 MAP kinase is required for AVP-stimulated HSP27 induction in vascular SMC, and the activation of p38 MAP kinase is dependent on PKC.
|
Acknowledgments |
|---|
We are grateful to Kouseki Hirade, Daijiro Hatakeyama, and Masaichi Miwa for their skillful technical assistance.
Received February 12, 1999; first decision March 10, 1999; accepted September 29, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Benjamin IJ, Mcmillan DR. Stress (heat shock) proteins: molecular chaperons in cardiovascular biology and disease. Circ Res. 1998;83:117–132.
2.
Kato K, Shinohara H, Kurobe N, Inaguma Y, Shimizu K,
Ohshima K. Tissue distribution and developmental profiles of
immunoreactive B crystallin in the rat determined with a
sensitive immunoassay system. Biochim Biophys Acta. 1991;1074:201–208.[Medline]
[Order article via Infotrieve]
3.
Inaguma Y, Goto S, Shinohara H, Hasegasa K, Ohshima K,
Kato K. Physiological and pathological changes in
levels of 2 small stress proteins, HSP27 and B crystallin, in
rat hind limb muscles. J Biochem. 1993;114:378–384.
4. Udelsman R, Blake MJ, Stagg CA, Li DG, Putney DJ, Holbrook NJ. Vascular heat shock protein expression in response to stress. J Clin Invest. 1993;91:465–473.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809.[Medline] [Order article via Infotrieve]
6. Scott-Burden T, Hahn AWA, Buhler FR, Resink TL. Vasoactive peptides and growth factors in the pathophysiology of hypertension. J Cardiovasc Pharmacol. 1992;20:S55–S64.
7. van Breemen C. Cellular mechanisms regulating [Ca2+]i smooth muscle. Annu Rev Physiol. 1989;51:315–329.[Medline] [Order article via Infotrieve]
8.
Grillone LR, Clark MA, Godfrey RW, Stassen F, Crooke
ST. Vasopressin induces V1 receptors to activate
phosphatidylinositol- and phosphatidylcholine-specific phospholipase C
and stimulates the release of arachidonic acid by at
least 2 pathways in the smooth muscle cell line, A-10. J
Biol Chem. 1988;263:2658–2663.
9. Plevin R, Stewart A, Paul A, Wakelam MJO. Vasopressin-stimulated [3H]-inositol phosphate, and [3H]-phosphatidyl-butanol accumulation in A10 vascular smooth muscle cells. Br J Pharmacol. 1992;107:109–115.[Medline] [Order article via Infotrieve]
10. Miwa M, Kozawa O, Suzuki A, Watanabe Y, Shinoda J, Oiso Y. Vasopressin activates phospholipase D through pertussis toxin-insensitive GTP-binding protein in aortic smooth muscle cells: function of Ca2+/calmodulin. Biochem Cell Biol. 1995;73:191–199.[Medline] [Order article via Infotrieve]
11. Billah MM, Anthes JC. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J. 1990;269:281–291.[Medline] [Order article via Infotrieve]
12.
Nishizuka Y. Studies and perspectives of protein kinase
C. Science. 1986;233:305–312.
13.
Cramelo C, Okada K, Tsai P, Schrier RW. Phorbol esters
and arginine vasopressin in vascular smooth muscle cell activation.
Am J Physiol. 1989;256:F875–F881.
14. Kaida T, Kozawa O, Ito T, Tanabe K, Ito H, Matsuno H, Niwa M, Miyata H, Uematsu T, Kato K. Vasopressin stimulates the induction of heat shock protein 27 and (B-crystallin via protein kinase C activation in vascular smooth muscle cells. Exp Cell Res. 1999;246:327–337.[Medline] [Order article via Infotrieve]
15. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 1993;18:128–131.[Medline] [Order article via Infotrieve]
16.
Widmann C, Gibson S, Jarpe MB, Johnson GL.
Mitogen-activated protein kinase: conservation of a
three-kinase module from yeast to human. Physiol Rev. 1999;79:143–180.
17.
Kato K, Goto S, Hasegawa K, Inaguma Y. Coinduction of 2
low-molecular-weight stress proteins, B crystallin and HSP28,
by heat or arsenite stress in human glioma cells. J
Biochem. 1993;114:640–647.
18.
Cooper LF, Uoshima K. Differential estrogenic
regulation of small Mr heart shock protein expression in osteoblasts.
J Biol Chem. 1994;269:7869–7873.
19.
Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A
synthetic inhibitor of the mitogen-activated
protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686–7689.
20. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995;364:229–233.[Medline] [Order article via Infotrieve]
21. Kummer JL, Rao PK, Heidenreich KA. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem. 1997;282:20490–20494.
22.
Toullec D, Pianetti P, Coste H, Bellevergue P,
Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F.
The bisindolylmaleimide GF109203X is a potent and selective
inhibitor of protein kinase C. J Biol Chem. 1991;266:15771–15781.
23. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:548–553.[Medline] [Order article via Infotrieve]
24. Oishi K, Zheng B, White JF, Vogler WR, Kuo JF. Inhibition of Na, K-ATPase and sodium pump by anticancer ether lipids and protein kinase C inhibitors ET-18-OCH3 and BM 41.440. Biochem Biophys Res Commun. 1988;157:1000–1006.[Medline] [Order article via Infotrieve]
25.
Kato K, Hasegawa K, Goto S, Inaguma Y. Dissociation as
a result of phosphorylation of an aggregated form of
the small stress protein, hsp27. J Biol Chem. 1994;269:11274–11278.
26.
Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J,
Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and
environmental stress cause p38 mitogen-activated protein kinase
activation by dual phosphorylation on tyrosine and
threonine. J Biol Chem. 1995;270:7420–7426.
27.
Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, Padova
FD, Ulevitvh RJ, Han J. Characterization of the structure and
function of the fourth member of p38 group mitogen-activated
protein kinase, p38. J Biol Chem. 1997;282:30122–30128.
28.
Lavoie JN, Hickey E, Weber LA, Landry J. Modulation of
actin microfilament dynamics and fluid phase pinocytosis by
phosphorylation of heat shock protein 27. J
Biol Chem. 1993;268:24210–24214.
29. Huot J, Lambert H, Lavoie JN, Guimond A, Houle F, Landry J. Characterization of 45-kDa/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat-shock protein HSP27. Eur J Biochem. 1995;227:416–427.[Medline] [Order article via Infotrieve]
30. Brophy CM, Woodrum D, Dickinson M, Beall A. Thrombin activates MAPKAP2 kinase in vascular smooth muscle. J Vasc Surg. 1998;27:963–969.[Medline] [Order article via Infotrieve]
31. Slepian MJ, Massia SP, Whitesell L. Pre-conditioning of smooth muscle cells via induction of the heat shock response limits proliferation following mechanical injury. Biochem Biophys Res Commun. 1996;225:600–607.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  B. Teng, W. Qin, H. R. Ansari, and S. J. Mustafa Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2574 - H2580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. von Offenberg Sweeney, P. M Cummins, Y. A Birney, J. P Cullen, E. M Redmond, and P. A Cahill Cyclic strain-mediated regulation of endothelial matrix metalloproteinase-2 expression and activity Cardiovasc Res, September 1, 2004; 63(4): 625 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tanaka, M. V. Gavrielides, Y. Mitsuuchi, T. Fujii, and M. G. Kazanietz Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival Pathway J. Biol. Chem., September 5, 2003; 278(36): 33753 - 33762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ohanian, P. Cunliffe, E. Ceppi, A. Alder, E. Heerkens, and V. Ohanian Activation of p38 Mitogen-Activated Protein Kinases by Endothelin and Noradrenaline in Small Arteries, Regulation by Calcium Influx and Tyrosine Kinases, and Their Role in Contraction Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1921 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cattaruzza, I. Eberhardt, and M. Hecker Mechanosensitive Transcription Factors Involved in Endothelin B Receptor Expression J. Biol. Chem., September 28, 2001; 276(40): 36999 - 37003. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||